|
PAHC | Phibro Animal Health Corp |
|
|
PAHC | Phibro Animal Health Corp |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.72 |
| Leverage | 75.88% |
| Market Cap | $ 1.4B |
| PE | 15.05 |
| Dividend Yield | 1.37% |
| Profit | $ 94.7m |
| Margin | 6.34% |
Phibro Animal Health Corporation develops, manufactures and supplies a range of mineral nutrition and animal health products for livestock primarily in the United States. The company is headquartered in Teaneck, New Jersey.